The Masonic Cancer Center (MCC) has been effective in its strategies to plan for and evaluate its mission The MCC has multiple internal and external resources for the planning and evaluation. Mechanisms for planning and evaluation include an External Advisory Board (EAB), Executive Committee with several subcommittees (Clinical and Translational Research Leadership, Science Council, Phase I Cancer Experimental Therapeutics Committee, Cancer Prevention and Control Steering Committee), Academic Health Center Planning and Reviews, Facility Planning Committees, and Minnesota Medical Foundation Capital Committee. MCC leaders and faculty also have leadership roles in other institutional units within the University. CCSG funds have and will be used to support the annual EAB meetings. In order to respond to the recommendations of the EAB and to increase the productivity of our basic, translational, and clinical research endeavors, the MCC holds periodic retreats and other meetings to develop strategic plans and goals. In the past funding period, we set the following strategic priorities and took steps to address each of them. ? Expand the resources for translational research ? Develop mechanisms to support the development of multi-investigator grants to expand translational capabilities ? Increase research capabilities by expanding research space and recruiting new laboratory-based investigators ? Create a new Cancer Detection, Treatment, and Survivorship (CaDeTS) research program or focus ? Refocus the Tumor Biology and Progression Program and the Women's Cancer Programs ? Integrate the Oncology Service Line into MCC operations and leadership, leveraging the research programs, clinical expertise, and resources ? Support health disparities research with MCC resources

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA077598-16
Application #
8633139
Study Section
Subcommittee G - Education (NCI)
Project Start
1998-06-01
Project End
2019-01-31
Budget Start
2014-03-05
Budget End
2015-01-31
Support Year
16
Fiscal Year
2014
Total Cost
$70,118
Indirect Cost
$61,605
Name
University of Minnesota Twin Cities
Department
Type
DUNS #
555917996
City
Minneapolis
State
MN
Country
United States
Zip Code
55455
Pang, Jiuxia; Shen, Na; Yan, Fei et al. (2017) Thymoquinone exerts potent growth-suppressive activity on leukemia through DNA hypermethylation reversal in leukemia cells. Oncotarget 8:34453-34467
Lin, Weiming; Modiano, Jaime F; Ito, Daisuke (2017) Stage-specific embryonic antigen: determining expression in canine glioblastoma, melanoma, and mammary cancer cells. J Vet Sci 18:101-104
Winterhoff, Boris J; Maile, Makayla; Mitra, Amit Kumar et al. (2017) Single cell sequencing reveals heterogeneity within ovarian cancer epithelium and cancer associated stromal cells. Gynecol Oncol 144:598-606
Jaramillo, Ericka G; Mupere, Ezekiel; Opoka, Robert O et al. (2017) Delaying the start of iron until 28 days after antimalarial treatment is associated with lower incidence of subsequent illness in children with malaria and iron deficiency. PLoS One 12:e0183977
Zhao, Xianda; Li, Lihua; Starr, Timothy K et al. (2017) Tumor location impacts immune response in mouse models of colon cancer. Oncotarget 8:54775-54787
Lynn, Geoffrey E; Oliver, Jonathan D; Cornax, Ingrid et al. (2017) Experimental evaluation of Peromyscus leucopus as a reservoir host of the Ehrlichia muris-like agent. Parasit Vectors 10:48
Luangphakdy, Viviane; Elizabeth Pluhar, G; Piuzzi, Nicolás S et al. (2017) The Effect of Surgical Technique and Spacer Texture on Bone Regeneration: A Caprine Study Using the Masquelet Technique. Clin Orthop Relat Res 475:2575-2585
Boylan, Kristin L M; Buchanan, Petra C; Manion, Rory D et al. (2017) The expression of Nectin-4 on the surface of ovarian cancer cells alters their ability to adhere, migrate, aggregate, and proliferate. Oncotarget 8:9717-9738
Mallhi, K; Orchard, P J; Miller, W P et al. (2017) Non-myeloablative conditioning for second hematopoietic cell transplantation for graft failure in patients with non-malignant disorders: a prospective study and review of the literature. Bone Marrow Transplant 52:726-732
Richardson, Paul G; Smith, Angela R; Triplett, Brandon M et al. (2017) Earlier defibrotide initiation post-diagnosis of veno-occlusive disease/sinusoidal obstruction syndrome improves Day +100 survival following haematopoietic stem cell transplantation. Br J Haematol 178:112-118

Showing the most recent 10 out of 957 publications